Show simple item record

dc.contributor.authorAboy, Mateoen
dc.contributor.authorCrespo, Cristinaen
dc.contributor.authorLiddell, Kathleenen
dc.contributor.authorMinssen, Timoen
dc.contributor.authorLiddicoat, Johnen
dc.date.accessioned2019-10-21T23:30:09Z
dc.date.available2019-10-21T23:30:09Z
dc.date.issued2019-05en
dc.identifier.issn1087-0156
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/297940
dc.description.abstractOn the sixth anniversary of Mayo v. Prometheus, what impact has the US Supreme Court decision had on patent subject-matter eligibility and the prosecution of biotech-related patent applications before the US Patent and Trademark Office?
dc.format.mediumPrinten
dc.languageengen
dc.rightsAll rights reserved
dc.rights.uri
dc.subjectHumansen
dc.subjectBiotechnologyen
dc.subjectSupreme Court Decisionsen
dc.subjectUnited Statesen
dc.subjectPatents as Topicen
dc.subjectPrecision Medicineen
dc.titleMayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine.en
dc.typeArticle
prism.endingPage518
prism.issueIdentifier5en
prism.publicationDate2019en
prism.publicationNameNature biotechnologyen
prism.startingPage513
prism.volume37en
dc.identifier.doi10.17863/CAM.44994
dcterms.dateAccepted2019-02-04en
rioxxterms.versionofrecord10.1038/s41587-019-0111-5en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-05en
dc.contributor.orcidAboy, Mateo [0000-0002-5168-4321]
dc.contributor.orcidMinssen, Timo [0000-0002-3286-4888]
dc.contributor.orcidLiddicoat, Johnathon [0000-0001-7370-3936]
dc.identifier.eissn1546-1696
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idNovo Nordisk Foundation (via University of Copenhagen) (NNF17SA0027784)
rioxxterms.freetoread.startdate2019-11-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record